Corrigendum to "Brain Activation and Psychomotor Speed in Middle-Aged Patients with Type 1 Diabetes: Relationships with Hyperglycemia and Brain Small Vessel Disease".
 M. Hwang, D. L. Tudorascu, K. Nunley et al., "Brain activation and psychomotor speed in middle-aged patients with type 1 diabetes: relationships with hyperglycemia and brain small vessel disease," Journal of Diabetes Research, vol. 2016, Article ID 9571464,11 pages, 2016.
Misun Hwang, (1) Dana L. Tudorascu, (2) Karen Nunley, (3) Helmet Karim, (4) Howard J. Aizenstein, (5) Trevor J. Orchard, (6) Caterina Rosano (7)
(1) Department of Radiology, University of Pittsburgh, 3600 Forbes Avenue, Plaza Level, Pittsburgh, PA 15213, USA
(2) Department of Internal Medicine, Department of Psychiatry, and Department of Biostatistics, University of Pittsburgh, 200 Meyran Avenue, Suite 326, Pittsburgh, PA 15213, USA
(3) Department of Epidemiology, University of Pittsburgh, 130 N. Bellefield Avenue, Suite 443, Pittsburgh, PA 15213, USA
(4) Department of Bioengineering, University of Pittsburgh, 253 Sterling Plaza, Pittsburgh, PA 15213, USA
(5) Department of Psychiatry, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA 15213, USA
(6) Department of Epidemiology, University of Pittsburgh, 3512 Fifth Avenue, Pittsburgh, PA 15213, USA
(7) Department of Epidemiology University of Pittsburgh, 130 N. Bellefield Avenue, Suite 467, Pittsburgh, PA 15213, USA
Correspondence should be addressed to Caterina Rosano; email@example.com
Received 17 October 2016; Accepted 25 October 2016; Published 16 March 2017
Table 3: Regions with functional activation that were correlated with performing the task in the scanner (main effect): positive associations are listed first and negative associations are listed next. Regions Cluster size Peak T-Score Montreal (df = 84) Neurological Institute coordinate for Peak T-Score Regions with activation positively correlated with main effect Superior parietal 6912 12 -28, -62, 52 (1) lobe, bilaterally Left middle frontal 3529 12 -44, 2, 34 (2) gyrus Right middle frontal 3133 8.5 36, 2, 52 (3) gyrus Medial frontal 1196 8.6 2, 20, 46 (4) gyrus, bilaterally Right inferior 375 6.3 34, 24, -5 (5) frontal gyrus Right thalamus 214 4 18, -6, 19 Left thalamus 212 4.1 -16, -12, 16 Regions with activation negatively correlated with main effect Left superior 1285 -6.6 -66, -22, 1 temporal gyrus Right superior 891 -5 56, -30, 22 temporal gyrus Posterior cingulate 821 -6.1 -4, -52, 28 cortex, bilaterally Left medial frontal 420 -5.1 -2, 64, 1 gyrus Right postcentral 418 -5.9 48, -26, 64 gyrus This table reports the spatial distribution of the mean group activation (obtained from the DSST > control condition contrast and from the control condition > DSST contrast), including the size of cluster, the maximum Z statistic for the cluster, and the location of the maximum Z statistic in Montreal Neurological Institute coordinates. The corrected alpha is the probability of false positive detection based on the combination of individual voxel probability thresholding and minimum cluster size thresholding. (1) This cluster extends medially to include the precuneus and caudally to include the superior occipital gyrus; it includes the most dorsal part of the inferior parietal lobule. (2) This cluster extends rostrally to include the supplementary motor area, caudally to include the precentral gyrus, and medially to include the insula. (3) This cluster extends rostrally to include the supplementary motor area, caudally to include the precentral gyrus, and ventrally to include the inferior frontal gyrus. (4) This cluster extends caudally in the right hemisphere to include the dorsal cingulate cortex. (5) This cluster covers part of the insula.
|Printer friendly Cite/link Email Feedback|
|Author:||Hwang, Misun; Tudorascu, Dana L.; Nunley, Karen; Karim, Helmet; Aizenstein, Howard J.; Orchard, Trev|
|Publication:||Journal of Diabetes Research|
|Article Type:||Correction notice|
|Date:||Jan 1, 2017|
|Previous Article:||Relationship between Immunological Abnormalities in Rat Models of Diabetes Mellitus and the Amplification Circuits for Diabetes.|
|Next Article:||Renoprotective Effect of the Shen-Yan-Fang-Shuai Formula by Inhibiting TNF-[alpha]/NF-[kappa]B Signaling Pathway in Diabetic Rats.|